V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16626432 | 330006593 | EWR01 | 1 | X724 | 1 | null | NOT CHEMO | 330002765 | 330003342 | 330006594 |
| 16626433 | 330006594 | EEI00 | 150 | x724 | 1 | 2016-12-13 | VINCRISTINE | 330002779 | 330007782 | 330006595 |
| 16626434 | 330006594 | EUZ | 300 | X292 | 1 | 2016-12-13 | NOT CHEMO | 330002779 | 330007782 | 330006595 |
| 16626435 | 330006594 | ERS12 | 1.05 | null | 1 | 2016-12-13 | VINCRISTINE | 330002779 | 330007782 | 330006595 |
| 16626436 | 330006594 | EPH | 500 | X724 | 1 | 2016-12-13 | NOT CHEMO | 330002779 | 330007782 | 330006595 |
| 16626437 | 330006594 | ECL02 | 16 | X724 | 1 | 2016-12-13 | IFOSFAMIDE | 330002779 | 330007782 | 330006595 |
| 16626438 | 330006594 | EUZ | 150 | X724 | null | 2016-12-13 | CYCLOPHOSPHAMIDE | 330002779 | 330007782 | 330006595 |
| 16626439 | 330006594 | ELW | 250 | X724 | 1 | 2016-12-14 | NOT CHEMO | 330002779 | 330007782 | 330006595 |
| 16626440 | 330006594 | EN201 | 1100 | X721 | 1 | 2016-12-14 | FLUOROURACIL | 330002779 | 330007782 | 330006595 |
| 16626441 | 330006594 | ENW | 8 | X724 | 1 | 2016-12-18 | CARBOPLATIN | 330002779 | 330007782 | 330006595 |
| 16626442 | 330006595 | EEI00 | 1.5 | null | 1 | 2016-09-07 | DACTINOMYCIN | 330002800 | 330003343 | 330006596 |
| 16626443 | 330006595 | EE813 | 20 | null | 1 | 2016-09-07 | CETUXIMAB | 330002800 | 330003343 | 330006596 |
| 16626444 | 330006595 | EUZ | 55 | X721 | 1 | 2016-09-08 | VINCRISTINE | 330002800 | 330003343 | 330006596 |
| 16626445 | 330006595 | ETG | 5600 | N/A | 1 | 2016-09-09 | DACTINOMYCIN | 330002800 | 330003343 | 330006596 |
| 16626446 | 330006598 | EE813 | 2700 | null | 1 | 2013-04-09 | NOT MATCHED | 330002811 | 330003346 | 330006599 |
| 16626447 | 330006598 | EK1EN | 2 | X721 | 1 | 2013-04-09 | IFOSFAMIDE | 330002811 | 330003346 | 330006599 |
| 16626448 | 330006599 | ERA20 | 55 | X729 | 1 | 2017-01-16 | CYTARABINE | 330002811 | 330003346 | 330006600 |
| 16626449 | 330006599 | E1UZ0 | 180 | X721 | 1 | 2017-01-16 | VINCRISTINE | 330002811 | 330003346 | 330006600 |
| 16626450 | 330006599 | EEI00 | 3800 | X724 | 1 | 2017-01-16 | TRIAL | 330002811 | 330003346 | 330006600 |
| 16626451 | 330006599 | EOI | 55 | X292 | 5 | 2017-01-16 | IFOSFAMIDE | 330002811 | 330003346 | 330006600 |
| 16626452 | 330006599 | EEI00 | 200 | X729 | null | 2017-01-23 | VINCRISTINE | 330002811 | 330003346 | 330006600 |
| 16626453 | 330006599 | EE813 | 0 | X729 | 1 | 2017-01-24 | ETOPOSIDE | 330002811 | 330003346 | 330006600 |
| 16626454 | 330006600 | EGU08 | 2040 | null | 1 | 2018-03-30 | STEROID | 330002818 | 330003348 | 330006601 |
| 16626455 | 330006600 | EE813 | 2020 | null | 1 | 2018-03-31 | ETOPOSIDE | 330002818 | 330003348 | 330006601 |
| 16626456 | 330006600 | EXO | 74 | X729 | 1 | 2018-04-07 | STEROID | 330002818 | 330003348 | 330006601 |
| 16626458 | 330006605 | EEI00 | 80 | X729 | 1 | 2016-05-07 | CISPLATIN | 330002835 | 330003352 | 330006606 |
| 16626459 | 330006605 | EJRNN | 1.05 | null | 1 | 2016-05-07 | TOPOTECAN | 330002835 | 330003352 | 330006606 |
| 16626460 | 330006605 | EEI00 | 180 | X721 | 1 | 2016-05-07 | CYTARABINE | 330002835 | 330003352 | 330006606 |
| 16626461 | 330006605 | EKA | 2640 | X721 | 1 | 2016-05-08 | IFOSFAMIDE | 330002835 | 330003352 | 330006606 |
| 16626462 | 330006605 | EN723 | 550 | X724 | 1 | 2016-05-08 | STEROID | 330002835 | 330003352 | 330006606 |
| 16626463 | 330006605 | EEI00 | 0 | null | 1 | 2016-05-09 | IFOSFAMIDE | 330002835 | 330003352 | 330006606 |
| 16626464 | 330006605 | EW100 | 5200 | X721 | 1 | 2016-05-09 | FLUOROURACIL | 330002835 | 330003352 | 330006606 |
| 16626465 | 330006606 | EEI00 | 80 | X729 | 1 | 2016-03-02 | CETUXIMAB | 330002838 | 330003354 | 330006607 |
| 16626466 | 330006607 | EOI | 3040 | null | 1 | null | CYCLOPHOSPHAMIDE | 330002843 | 330003356 | 330006608 |
| 16626467 | 330006607 | EOI | 2960 | null | 1 | null | IFOSFAMIDE | 330002843 | 330003356 | 330006608 |
| 16626468 | 330006607 | E1UZ0 | 60 | X724 | 1 | null | METHOTREXATE | 330002843 | 330003356 | 330006608 |
| 16626469 | 330006608 | E1UZ0 | 3700 | X292 | 1 | 2017-05-21 | TOPOTECAN | 330002843 | 330003356 | 330006609 |
| 16626470 | 330006608 | EEI00 | 2960 | null | 1 | 2017-05-21 | MESNA | 330002843 | 330003356 | 330006609 |
| 16626471 | 330006608 | ED301 | 3600 | X724 | 1 | 2017-05-22 | ETOPOSIDE | 330002843 | 330003356 | 330006609 |
| 16626472 | 330006609 | EEI00 | 4 | X729 | 1 | 2016-09-10 | MULTIPLE | 330002844 | 330003357 | 330006610 |
| 16626473 | 330006611 | ECL02 | 4000 | x724 | 1 | 2016-08-15 | MULTIPLE | 330002870 | 330003359 | 330006612 |
| 16626474 | 330006612 | ECL02 | 72 | X729 | 1 | 2016-12-22 | NOT CHEMO | 330002870 | 330003359 | 330006613 |
| 16626475 | 330006613 | EEI00 | 78 | null | 1 | 2014-03-26 | MESNA | 330002875 | 330003360 | 330006614 |
| 16626476 | 330006613 | EOI | 0 | null | 1 | 2014-03-28 | TRIAL | 330002875 | 330003360 | 330006614 |
| 16626477 | 330006613 | ETG | 90 | X721 | 1 | 2014-03-28 | NOT MATCHED | 330002875 | 330003360 | 330006614 |
| 16626478 | 330006613 | EGU08 | 2640 | X724 | 1 | 2014-03-31 | DACTINOMYCIN | 330002875 | 330003360 | 330006614 |
| 16626479 | 330006613 | E0N03 | 210 | N/A | 1 | 2014-03-31 | STEROID | 330002875 | 330003360 | 330006614 |
| 16626480 | 330006613 | EE813 | 1.5 | null | 1 | 2014-04-01 | VINCRISTINE | 330002875 | 330003360 | 330006614 |
| 16626481 | 330006613 | EJU04 | 1700 | X721 | 1 | 2014-04-03 | FLUOROURACIL | 330002875 | 330003360 | 330006614 |
| 16626482 | 330006613 | EII | 4440 | null | 1 | 2014-04-06 | FLUOROURACIL | 330002875 | 330003360 | 330006614 |